Drug Shortage Report for ROFACT

Last updated on 2020-02-04 History
Report ID 93246
Drug Identification Number 00343617
Brand name ROFACT
Common or Proper name ROFACT
Company Name BAUSCH HEALTH, CANADA INC.
Active Ingredient(s) RIFAMPIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size n/a
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-15
Estimated end date 2020-03-01
Actual end date
Shortage status Actual shortage
Updated date 2020-02-04
Company comments currently on manual allocation; new API submission, awaiting response from HC
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-02-04 French Compare
v20 2020-02-04 English Compare
v19 2020-02-03 French Compare
v18 2020-02-03 English Compare
v17 2020-01-23 French Compare
v16 2020-01-23 English Compare
v15 2020-01-16 French Compare
v14 2020-01-16 English Compare
v13 2020-01-15 French Compare
v12 2020-01-15 English Compare
v11 2020-01-09 French Compare
v10 2020-01-09 English Compare
v9 2020-01-09 English Compare
v8 2019-12-11 French Compare
v7 2019-12-11 English Compare
v6 2019-09-09 French Compare
v5 2019-09-09 English Compare
v4 2019-09-09 French Compare
v3 2019-09-09 English Compare
v2 2019-09-06 French Compare

Showing 1 to 20 of 21